Tuesday, January 25, 2011

Quintiles Speeds Early-Phase Decision Making with New Unit in Hyderabad, India

Further Expands Global Phase I Offering

TRIANGLE PARK, N.C - Monday, January 24th 2011 [ME NewsWire]

(BUSINESS WIRE)-- Quintiles, the only fully integrated bio pharmaceutical services company offering clinical, commercial, consultingand capitalsolutions worldwide, today officially opened its new Phase Iresearch facility in Hyderabad, India at Apollo Health City.

Constructed in partnership with Apollo Hospitals Group, the new facility will complement Quintiles existing Phase I facilities around the globeto help customers navigate complex early development challenges and make key decisions early. It will provide biopharma customers additional options to complete integrated Phase I programsacross multiple geographies at this pivotal stage in medical research.

Eddie Caffrey, Senior Vice President and Head of Quintiles Phase I globally comments: “Sponsors, are under intense pressure to speed delivery of results, ethically, and without compromising patient safety or quality of data. With this new, state of the art, Phase I facility in Hyderabad, India, we will be better able to ally with customers by providing access to large numbers of healthy volunteers for simple studies, in parallel to more complex studies conducted by scientific experts in Europe and the US.”

“We are excited to be working with Quintiles to deliver high quality Phase I studies for international customers in India. Apollo has pioneered the provision of many medical and surgical procedures in India and our mission is to bring healthcare of international standards to within the reach of every individual,” says Ms. Shobana Kamineni, Executive Director, Apollo Hospitals Group.

“With this new unit we are reinforcing India’s position as a key player in the global drug development market and expanding the options available to pharma sponsors.”

The team in Hyderabad under leadership of Ashish Jain, Executive Director will work to global standards and procedures and will be connected to sites in London, Uppsala and Kansas through Quintiles global data network to simplify study management for sponsors and provide integrated information and perspective as early as possible in the development process.

The 86-bed unit will evaluate compounds developed both in India and in other countries. Data capture will be linked electronically to Quintiles other Phase I units in UK, US, and Sweden. Thirty two beds are equipped with technically advanced diagnostic cardiology equipment for TQT studies.

In addition, this unique Phase 1 facility at Apollo Health City, Hyderabad, Quintiles also has offices in India, with existing operations in Ahmedabad, Bangalore, Delhi, and Mumbai. Expertise across the country covers a wide range of therapeutic areas, including leading physicians and experts in the areas of oncology, CNS, infectious disease, and cardiovascular disease.

About Quintiles

Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of more than 20,000 engaged professionals in 60 countries works with an unwavering commitment to patients, safety and ethics. Quintiles helps bio-pharmaceutical companies navigate risk and seize opportunities in an environment where change is constant. For more information, please visit www.quintiles.com.

About Apollo Hospitals

In 1983, Dr Prathap C Reddy, the architect of Indian healthcare, launched the first corporate hospital in India. An integrated healthcare company, the Apollo Hospitals Group has over 8,500 beds across 50 hospitals, more than 1200 pharmacies and 100 diagnostic clinics, medical business process outsourcing services, health insurance services, and clinical research divisions with a focus on epidemiological studies, stem cell research and genetic research. To develop talent for the burgeoning need of superior healthcare delivery, the Apollo Hospitals Group has 11 nursing and hospital management colleges. These accomplishments have earned Apollo Hospitals Group accolades such as the Centre of Excellence from the Government of India and recognition from the Joint Commission International (seven of our hospitals are JCI accredited). In a rare honour, the Government of India issued a commemorative stamp in recognition of Apollo's contribution, the first for a healthcare organization. Apollo, for over 26 years, has continuously excelled and maintained leadership in medical innovation, world-class clinical services and cutting edge research. Our hospitals are consistently ranked amongst the best hospitals globally for advanced medical services. For more information, please visit www.apollohospitals.com

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6582276〈=en


Jay Johnson +1 919 998 2066


Laura Wilson



Jane Yeo



No comments:

Post a Comment